McKesson Corporation (NYSE: MCK), a leading healthcare services and
information technology company, and PSS World Medical, Inc. (NASDAQ:
PSSI), announced today that McKesson has voluntarily withdrawn and
re-filed its notification and report form filed under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR
Act") in connection with the proposed acquisition by McKesson of PSS
World Medical. As previously announced on October 25, 2012, McKesson and
PSS World Medical have signed a definitive agreement under which
McKesson will acquire all outstanding shares of PSS World Medical for
$29.00 per share in cash.
Upon re-filing of the HSR Act notification and report forms, the Federal
Trade Commission will have an additional 30-day period in which to
determine whether to clear the proposed transaction or issue a request
for additional information and documentary material, commonly referred
to as a "second request." McKesson and PSS World Medical look forward to
continuing to work cooperatively and constructively with the Federal
Trade Commission as it conducts its review of the proposed transaction.
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a
healthcare services and information technology company dedicated to
making the business of healthcare run better. We partner with payers,
hospitals, physician offices, pharmacies, pharmaceutical companies and
others across the spectrum of care to build healthier organizations that
deliver better care to patients in every setting. McKesson helps its
customers improve their financial, operational, and clinical performance
with solutions that include pharmaceutical and medical-surgical supply
management, healthcare information technology, and business and clinical
services. For more information, visit http://www.mckesson.com.
About PSS World Medical, Inc.
PSS World Medical, Inc. (Nasdaq:PSSI) markets and distributes medical
products and services to front-line caregivers throughout the United
States. With 4,000 team members, PSS is a leader in the markets it
serves with innovative approaches to customer service and operational
excellence. Its stated purpose is to strengthen the clinical success and
financial health of caregivers by solving their biggest problems. The
Company is focused to accelerate growth in four markets - Physician,
Laboratory, Dispensing, and Home Care & Hospice - with products and
solutions that deliver high quality, cost effective, and convenient
patient care. For more information on PSS, visit www.pssworldmedical.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121210006321/en/
[ Back To NFVZone's Homepage ]